Supplementary material
The Supplementary Material for this article can be found online at: Individual SG measures for participant during the entire study period for dual-hormone (blue) and single-hormone (pink). Black dotted lines mark the lower and upper boundary of target glycemic range of 3.9 mmol/L to 10.0 mmol/L, respectively.Click here for additional data file.Mean (±SD) basal insulin (IE) delivered during the entire study period for dual-hormone (blue) and single-hormone (pink). Sleep and exercise periods marked in the figure.Click here for additional data file.Mean (±SD) total insulin (IE) delivered during the entire study period for dual-hormone (blue) and single-hormone (pink). Sleep and exercise periods marked in the figure.Click here for additional data file.Mean (±SD) bolus insulin (IE) delivered during the entire study period for dual-hormone (blue) and single-hormone (pink). Sleep and exercise periods marked in the figure.Click here for additional data file.Individual insulin delivery for each participant during the entire study period for dual-hormone (blue) and single-hormone (pink).Click here for additional data file.Mean glucagon delivery during the entire dual-hormone study period. Sleep and exercise periods marked in the figure.Click here for additional data file.Individual glucagon delivery for each participant during the entire dual-hormone study period.Click here for additional data file.